The present invention pertains to the field of surgical instruments and methods of use, in particular to a surgical instrument for the treatment of female urinary incontinence.
Women account for approximately 11 million of incontinence cases, annually. Moreover, a majority of women with incontinence suffer from stress urinary incontinence (SUI). Women with SUI involuntarily lose urine during normal daily activities and movements, such as laughing, coughing, sneezing and regular exercise.
SUI may be caused by a functional defect of the tissue or ligaments connecting the vaginal wall with the pelvic muscles and the pubic bone. Common causes include repetitive straining of the pelvic muscles, childbirth, loss of pelvic muscle tone, and estrogen loss, wherein such a defect can result in an improperly functioning urethra. Unlike other types of incontinence, SUI is not a problem of the bladder.
Normally, the urethra, when properly supported by strong pelvic floor muscles and healthy connective tissue, maintains a tight seal to prevent involuntary loss of urine.
When a woman suffers from the most common form of SUI, however, weakened muscles and pelvic tissues are unable to adequately support the urethra in its correct position. As a result, during normal movements when pressure is exerted on the bladder from the diaphragm, for example, the urethra cannot retain its seal, permitting urine to escape. Because SUI is both embarrassing and unpredictable, many women with SUI may avoid an active lifestyle, shying away from social situations. There are many surgical procedures for the treatment of urinary stress incontinence. The suburethral sling of all of these procedures has shown the best results for all causes of urinary stress incontinence. The accepted procedures for treatment require abdominal incisions and are thus considered invasive procedures.
Tension free vaginal tape (TVT) is a relatively new surgical technique in treatment of female stress urinary incontinence and it is considered a modified suburethral sling. This procedure has revolutionized the surgical treatment of urinary stress incontinence because it is minimally invasive and has an effective cure rate of about 85-90%. The cost of disposable kits for this procedure is the main limiting factor and therefore translates into a limited number of procedures per centre, thereby limiting surgeons from offering this minimally invasive and effective procedure to every eligible patient.
U.S. Pat. No. 5,112,344 describes a method for treating female urinary incontinence without the necessity of opening the abdomen, which would require hospital care for a number of days. In this method, a tape is looped around the urethra to be implanted into the soft tissue between the vaginal wall and the abdominal wall extending above the pubis and with the ends of the tape extending into the abdominal wall. The tape is left in the body in order that fibrous scar tissue shall develop around the tape functioning as a supporting ligament in the soft tissue.
A surgical instrument for treating female urinary incontinence is also disclosed in U.S. Pat. No. 5,899,909. The instrument comprises a shank having a handle at one end thereof, and two curved needle-like elements, which are connected at one end thereof each with one end of a tape intended to be implanted into the body. These elements can be connected one at a time with the shank at the other end thereof to form a curved end portion of the shank and are intended to be passed into the body via the vagina, each element being dimensioned to extend from the inside of the vaginal wall over the back of the pubic bone to the outside of the abdominal wall. When practising the method the tape is passed into the body via the vagina first at one end and then at the other end at one side and the other, respectively, of the urethra to form a loop around the urethra, located between the urethra and the vaginal wall. The tape is extended over the pubis and through the abdominal wall and is tightened. Subsequently, the tape ends are cut at the abdominal wall, and the tape is left implanted in the body.
U.S. Pat. No. 6,406,423 discloses another method for the surgical treatment of urinary incontinence and the device for carrying out this method. The device includes a needle, an intermediate traction element, and a sleeved support tape; and the method includes forming an opening in the vaginal wall and forming suprapubic incisions, creating tracks and following one track with a needle and intermediate traction element from a suprapubic incision to the opening in the vagina, following the other track with a needle and optionally an intermediate traction element, verifying the tracks by cystoscopy, passing a sleeved tape through the tracks to form a loop under the urethra, adjusting the loop, removing the sleeve, and leaving the tape implanted.
Other surgical instruments and methods for treating female urinary incontinence are also disclosed in U.S. Pat. Nos. 6,273,852 and 6,491,703.
Each of the prior art surgical instrument devices, however, is capable of performing only a particular surgical method for treatment of female urinary incontinence. Therefore, the surgeon's selection of the surgical instrument device may be based upon the preferred surgical method. In addition, some or part of the surgical instruments of the prior art are not reusable and therefore this can increase the cost of performing the surgery. Therefore there is a need for an improved surgical instrument for the treatment of female urinary incontinence.
This background information is provided for the purpose of making known information believed by the applicant to be of possible relevance to the present invention. No admission is necessarily intended, nor should be construed, that any of the preceding information constitutes prior art against the present invention.
An object of the present invention is to provide a surgical instrument for the treatment of female urinary incontinence and methods of use. In accordance with an aspect of the present invention, there is provided a surgical instrument for treatment of female urinary incontinence, the surgical instrument comprising: a curved needle-like element having a first and a second end, each of the first and second ends of the curved needle-like element having an eye therethrough; and a handle having a first and second end, the first end having a gripping mechanism attached thereto for enabling a person to hold and manipulate the handle, the second end of the handle having a coupling means for releaseably securing the first end of the curved needle-like element to the handle; wherein a tape to be implanted into a female body as a loop around urethra is passed through one of the eyes in the curved needle-like element and subsequently drawn into the body thereby implanting the tape within the body.
The present invention provides a surgical instrument for use during a surgical procedure for the treatment of female urinary incontinence. The surgical instrument comprises a handle including a gripping mechanism providing a means for the surgeon to manipulate the surgical instrument. The handle further includes a coupling means enabling the interconnection of a curved needle-like element to the handle. The curved needle-like element has at least two eyes therethrough, wherein one eye is located in the proximity of the first end of the element and a second eye is located in the proximity of the opposite end of the needle-like element. During the surgical procedure, surgical tape is passed through one of the eyes and drawn through the body in a manner such that the surgical tape forms a suburethral sling, wherein the two ends of the surgical tape emerge from the abdominal wall. The suburethral sling can be positioned by using a vaginal approach or an abdominal approach, wherein the design of the surgical instrument according to the present inventions can be used for either of these surgical approaches.
Handle
The handle of the surgical instrument has a central shaft and two ends wherein one end of the handle has associated with it a gripping mechanism enabling one to hold and manipulate the surgical instrument. The opposite end of the handle has a coupling means associated therewith, which provides a means for rigidly connecting the curved needle-like element thereto. The coupling means is designed such that the curved needle-like element can be releasably connected to the handle.
In one embodiment of the invention and with reference to
The gripping mechanism can be interconnected with the shaft of the handle by welding, braising or soldering, for example. In one embodiment of the invention the gripping mechanism and the shaft of the handle can be manufactured as one unit, for example by casting the unit in a mould.
In one embodiment of the invention, the plane in which the gripping mechanism projects from the handle, is the same plane in which the curved needle-like element bends, as illustrated in
The end of the handle opposite to the gripping mechanism has a coupling means associated therewith. In one embodiment of the invention and with reference to
In one embodiment of the invention, biasing means are associated with the jaws of the coupling means forcing the jaws into an open orientation thereby providing for ease of insertion and removal of the needle-like element into and out of the coupling means of the handle. The biasing means can be a spring fabricated from surgical steel or stainless steel.
All of the parts of the handle as described so far are intended to be used several times and therefore should consist of a material which can be sterilised, for example by autoclaving or flash sterilisation. For example, the handle can be manufactured from stainless steel or other material, which has the specified properties as, would be readily understood by a worker skilled in the art of surgical instrument manufacture.
In one embodiment of the present invention, the handle can be readily disassembled, for example removing the jaws from the coupling means, in order that the sterilisation process may be performed in a potentially more complete manner.
Curved Needle-Like Element
The curved needle-like element has a first and second end wherein in the proximity of both the first and second ends, an eye has been provided therethrougli Since eyes are provided at both ends of the curved needle-like element, a surgical technique for the treatment of female incontinence involving either the vaginal approach or the abdominal approach to the surgery may be performed using the surgical instrument of the present invention.
With reference to
The shape of the eyes provided within the needle-like element can take any cross sectional shape for example a circle, ellipse, slot or elongated slot. In one embodiment of the invention, the cross sectional shape of the eyes is an elongated slot thereby potentially making the passing of a surgical tape therethrough easier.
The eyes, which are formed within the needle-like element at the first end and second end (free end) thereof, can be oriented in any direction with respect to the cross section of the needle-like element. The orientation of the eye within the needle-like element may be determined by the manufacturing technique of the element itself.
The curved needle-like element as described so far is intended to be used several times and therefore should consist of a material which can be sterilised, for example by autoclaving or flash sterilisation. For example, the curved needle-like element can be manufactured from stainless steel or other material that has the specified properties as would be readily understood by a worker skilled in the art of surgical instrument manufacture.
Upon the interconnection of the needle-like element and the handle, they form a rigid unit that can be controlled with great precision when the surgical instrument is used for the surgery applying the methods of the present invention.
Surgical Tape
The surgical tape of the present invention is implanted into the body in order to form a suburethral sling that may enable the treatment of female urinary incontinence. The surgical tape used to form the sling can be an autologous material such as rectus fascia or a heterologous material, which may be from an animate source or may be a synthetic material.
In one embodiment of the present invention, the tape comprises a mesh or netting forming openings of the order of 1 mm in order that fibroblasts can be able to grow into the tape for anchoring of the tape in surrounding tissue. A suitable material for the tape is PROLENEā¢, a knitted polypropylene mesh having a thickness of 0.7 mm manufactured by Ethicon, Inc., Sommerville, N.J., USA. This material is approved by FDA in USA for implantation into the human body.
In another embodiment of the present invention, the tape can be knitted or woven more closely than the tape mentioned above and can be of such material that the tape after a shorter or longer period of time may be completely resorbed by the body. By the development of fibroblast proliferation stimulated by the tape, the reinforcement of the tissue required in order to restore the urinary continence may be obtained.
In one embodiment, the material of the tape can be coated with a fibroblast stimulating substance, e.g. an enamel matrix derivative.
Method of Use by the Abdominal Approach
Initially the curved needle-like element and the handle are rigidly connected together. The first step of the surgery for implanting the tape is disclosed in
A first end of the surgical tape 109 is inserted into the eye of the needle-like element located at the free end thereof as shown in
A second needle-like element, or the original element, potentially having been resterilised, is rigidly connected to the handle of the surgical instrument. Similar as previously performed, the needle is passed through a second incision in the abdominal wall on the opposite side of the pubic bone, passing on the opposite side of the urethra and passing out the incision in the vaginal wall. The second end of the surgical tape is inserted into the eye and the needle-like element located at the free end. The needle-like element is subsequently withdrawn from the second abdominal incision together with the second end of the surgical tape.
In one embodiment, prior to the withdrawing of a needle-like element, the path of the needle-like element can be examined using cystoscopy in order that it can be verified that there has not been any puncture or damage to either the urethra or the bladder. This check can be performed once if two needle-like elements are used for the surgery, however two checks may be performed if only one needle-like element is used to perform the procedure. If two needle-like elements are used, the withdrawal of both needle-like elements and the drawing of the surgical tape into the body will occur upon inspection of the urethra and the bladder using cystoscopy.
The surgical tape is now located on either side of the urethra forming a loop there around. This loop can be adjusted thereby potentially optimising the support and/or restriction of the urethra. The excess of the tape on the outside of the abdominal wall can be cut off and the tape may be left as an implant in the body to form an artificial ligament, for example and potentially providing the support for the urethra as required to restore urinary continence.
Method of Use by the Vaginal Approach
Initially the curved needle-like element and the handle are rigidly connected together.
The first step of the surgery for implanting the tape is disclosed in
The handle of the surgical instrument is released from the needle-like element exposing the eye at the first end of the element. A first end of the surgical tape 100 is inserted into this eye of the needle-like element as shown in
A second needle-like element, or the original element, potentially having been resterilised, is rigidly connected to the handle of the surgical instrument. As initially performed, the needle is passed through the incision in the vaginal wall passing on the opposite side of the urethra and passing out an incision on the opposite side of the pubic bone, as illustrated in
In one embodiment, prior to the withdrawing of a needle-like element, the path of the needle-like element can be examined using cystoscopy in order that it can be verified that there has not been any puncture or damage to either the urethra or the bladder. This check can be performed once if two needle-like elements are used for the surgery, however two checks may be performed if only one needle-like element is used to perform the procedure. If two needle-like elements are used, the withdrawal of both needle-like elements and the drawing of the surgical tape into the body will occur upon inspection of the urethra and the bladder using cystoscopy.
The surgical tape is now located on either side of the urethra forming a loop there around. This loop can be adjusted thereby potentially optimising the support and/or restriction of the urethra. The excess of the tape on the outside of the abdominal wall can be cut off and the tape may be left as an implant in the body to form an artificial ligament and potentially providing the support for the urethra as required to restore urinary continence.
Randomized Control Trial Comparing Modified TVT Using Reusable Pubovaginal Sling Device in Treatment of Urinary Stress Incontinence
A randomized control trial was conducted comparing the surgical procedures, using the reusable pubovaginal sling device of the present invention (modified TVT procedure) and a standard Gynecare device (standard Gynecare TVT procedure), for the treatment of SUI.
Fifty patients with SUI were randomized into two groups for surgical treatment of SUL Each patient had a full history, gynecological and pelvic examination carried out. Each patient underwent a full urodynamic assessment including uroflometery and multichannel subtracted cystometry. The diagnosis of stress urinary incontinence was confirmed with objective demonstration of incontinence and leak point pressure analysis.
The first group of 25 patients underwent the modified TVT procedure using the reusable pubovaginal sling according to the present invention. The second group of 25 patients underwent the Gynecare TVT procedure using a standard Gynecare TVT device.
The two groups were comparable in patient demographics. The mean age for the Gynecare TVT group was 51.08 years compared to 51.88 years for the modified TVT group. This was not significant with a P-value of 0.78 (not significant). The parity similarly was 2.5 in Gynecare TVT group compared to 2.7 in the modified TVT Gynecare with a P-value of 0.74 (not significant). The body mass index in the Gynecare TVT group was 28.0 compared to 29.80 in the modified TVT group and a P-value of 0.31 (not significant). The type of incontinence in the patients, such as stress, mixed and recurrent, were comparable between the two groups with numbers of 16, 4 and 5 patients in the Gynecare. TVT group and 15, 5 and 5 patients in the modified TVT group, respectively (P-value 0.77 (not significant)). The leak point pressure in each group was 74.16 in the Gynecare TVT group compared to 71.25 in the modified TVT group with a P-value of 0.64 (not significant) (See Table 1).
The surgery time was comparable in the two groups with 27.76 minutes in the Gynecare TVT group compared to 25.62 minutes in modified TVT group and a P-value of 0.42 (not significant). The anaesthesia time, similarly, was comparable with 20.26 minutes in the Gynecare TVT group comparable to 23.60 minutes in the modified TVT group and a P-value of 0.12 (not significant). The resumption to normal voiding was comparable in the two groups with 0.60 days in the Gynecare TVT group compared to 0.45 days in modified TVT group and a P-value of 0.54 (not significant). The length of hospital stay was similar in the two groups with 0.84 days in the Gynecare TVT group compared to 0.72 days in modified TVT group with a P-value of 0.70 (not significant) (See Table 2).
The equipment cost of the Gynecare TVT group included the cost of the disposable surgical kit for the procedure. The cost of this kit was six hundred and seventy-five Canadian dollars ($675) compared to only ten dollars ($10) for a piece of mesh in modified TVT group. This difference was very significant with a P-value of less than 0.0001. The total cost including cost of surgery, anaesthetist fee, equipment cost and hospital stay was approximately 50% less in the modified TVT group. This value was with a mean of one thousand seven hundred and twelve dollars ($1,712) per patient in Gynecare TVT group compared to only nine hundred and ninety-seven dollars ($997) in modified TVT group. This difference again was statistically significant with a P-value of 0.01. The procedures were comparable as far as success was concerned at six weeks postoperatively and one year postoperatively. The six weeks success included 21 patients cured out of 25 (84%) in the Gynecare TVT group compared to 22 patients cured out of 25 (88%) in the modified TVT group. This was not significant with a P-value of 1.00. The surgical cure for one-year postoperatively was the same for both groups with 22 patients cured in each group and a success rate of 88% (see Table 3).
The modified pubovaginal TVT sling of the present invention can be as effective as the standard Gynecare TVT procedure. The procedure of modified TVT using a reusable pubovaginal sling device however has no upfront cost, apart from the initial purchase price of the device itself and the total cost is 50% less compared to standard TVT procedure.
The embodiments of the invention being thus described, it will be obvious that the same may be varied in many ways. Such variations are not to be regarded as a departure from the spirit and scope of the invention, and all such modifications as would be obvious to one skilled in the art are intended to be included within the scope of the following claims.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/CA04/00031 | 1/6/2004 | WO | 12/2/2005 |
Number | Date | Country | |
---|---|---|---|
60437993 | Jan 2003 | US |